My First Blog
Sunday, December 26, 2010
GSK offers UK rebate if Pfizer cancer drug better
LONDON (Reuters) - Britain's state-run health service will get a partial rebate from GlaxoSmithKline if the company's new kidney cancer drug Votrient does not match up to a rival medicine in a head-to-head clinical trial.
doctor oz
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment